Off-market insider buying at LSL Pharma Group (LSL)

Off-market insider buying at LSL Pharma Group (V:LSL)

Luc Mainville, a Senior Officer, acquired 875,000 Common Shares cat?gorie A on an indirect ownership basis at a price of $0.400 through a private transaction on March 18th, 2024. The insider also acquired 875,000 Warrants on an indirect ownership basis with an exercise price of $0.700 for 36 months. This represents a $350,000 investment into the company's shares and an account share holdings change of greater than 100%.

LSL Pharma Group is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

LSL Pharma Group Inc. is a Canadian integrated pharmaceutical company. The Company is specializing in the development, manufacturing and distribution of natural health products and dietary supplements in solid dosage forms, as well as sterile ophthalmic pharmaceutical products. The Company's subsidiaries include Steri-Med Pharma Inc., LSL Laboratory Inc. and Groupe Immobilier LSL inc.